Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.7573/dic.2020-4-1 http://scihub22266oqcxt.onion/10.7573/dic.2020-4-1 32699547!7357683!32699547     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Drugs+Context 2020 ; 9 (ä): ä Nephropedia Template TP {{tp|p=32699547|t=2020. Kawasaki disease in siblings and a review of drug treatment |pdf=|usr=}}{{32699547}} gab.com Text Kawasaki disease in siblings and a review of drug treatment JO: Drugs Context http://www.kidney.de/pget.php?&tw=1&pmid=32699547 #FOAvip We have managed two anonymized siblings with Kawasaki disease (KD). The occurrence of KD in the elder brother alerted us to the occurrence of incomplete KD in the younger brother. Both siblings were treated with intravenous immunoglobulin and a high dose of dipyridamole with resolution of the coronary artery aneurysm. Dipyridamole was used instead of aspirin because both siblings were glucose-6-phosphate dehydrogenase deficient for which aspirin was contraindicated. To prevent damage to the coronary arteries, treatment should be started as soon as the diagnosis is made. There have been a lot of advances in medical therapy in recent years, which are reviewed together with conventional proven therapy for KD. Early diagnosis and prompt treatment are important to achieve optimal treatment outcome in KD. Family history of KD among siblings enables clinicians for an earlier diagnosis so as to prevent the disease complications particularly in patients with incomplete features. Twit Text FOAVip Kawasaki disease in siblings and a review of drug treatment ????Drugs Context http://www.kidney.de/pget.php?&tw=1&pmid=32699547 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32699547 #FOAvip English Wikipedia <ref>{{Cite pmid|32699547}}</ref> Kawasaki disease in siblings and a review of drug treatment #MMPMID32699547 Loo SK; Hon KL; Leung AK; Yung TC; Yam MC Drugs Context 2020[]; 9 (ä): ä PMID32699547show ga We have managed two anonymized siblings with Kawasaki disease (KD). The occurrence of KD in the elder brother alerted us to the occurrence of incomplete KD in the younger brother. Both siblings were treated with intravenous immunoglobulin and a high dose of dipyridamole with resolution of the coronary artery aneurysm. Dipyridamole was used instead of aspirin because both siblings were glucose-6-phosphate dehydrogenase deficient for which aspirin was contraindicated. To prevent damage to the coronary arteries, treatment should be started as soon as the diagnosis is made. There have been a lot of advances in medical therapy in recent years, which are reviewed together with conventional proven therapy for KD. Early diagnosis and prompt treatment are important to achieve optimal treatment outcome in KD. Family history of KD among siblings enables clinicians for an earlier diagnosis so as to prevent the disease complications particularly in patients with incomplete features. äKawasaki disease in siblings and a review of drug treatment (epmc).pdf DeepDyve Pubget Overpricing